Mediatech and GlobalStem Form Strategic Alliance
Complete the form below to unlock access to ALL audio articles.
Mediatech, Inc. and GlobalStem, Inc. have recently formed a strategic alliance to develop, manufacture, validate, and distribute Embryonic Stem Cell-qualified growth media and supplements.
Mediatech contributes over 20 years of cGMP experience in the manufacture of sterile solutions while GlobalStem brings a wealth of knowledge and research in the field of embryonic stem cells (ESC).
Pluripotent ES cells are capable of self-renewal while maintaining the malleability to differentiate into other major cell types in the body.
This gives promise to the technology of cell replacement therapies aimed at remedying disease such as diabetes, Parkinson's, spinal cord injuries and stroke.
Human ES cells also provide a model for the study of normal human development.
